{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T18:36:16Z","timestamp":1763318176553,"version":"3.30.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.transproceed.2024.10.034","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T12:40:40Z","timestamp":1733316040000},"page":"2124-2133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Physician-Directed Mycophenolate Mofetil Dose Reduction After Kidney Transplantation: A Multicenter Real Word Experience"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-0897","authenticated-orcid":false,"given":"Hani M.","family":"Wadei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namrata","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Suliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Abdelrheem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter D.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byron H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie A.","family":"Schinstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Khamash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Stegall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2024.10.034_bib0001","doi-asserted-by":"crossref","first-page":"e1273","DOI":"10.1097\/TXD.0000000000001273","article-title":"Death with function and graft failure after kidney transplantation: risk factors at baseline suggest new approaches to management","volume":"8","author":"Merzkani","year":"2022","journal-title":"Transplant Direct"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajt.2023.02.004","article-title":"OPTN\/SRTR 2021 Annual Data Report: Kidney","volume":"23","author":"Lentine","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0003","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1600-6143.2003.30112.x","article-title":"Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection","volume":"3","author":"Meier-Kriesche","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0004","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.TP.0000062833.14843.4B","article-title":"Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration","volume":"75","author":"Meier-Kriesche","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0005","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0006","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0007","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0008","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-200107150-00014","article-title":"Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients","volume":"72","author":"Squifflet","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0009","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00007890-199801270-00018","article-title":"Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients","volume":"65","author":"Roth","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0010","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","article-title":"Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation","volume":"14","author":"Knoll","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/petr.12637","article-title":"Minimum mycophenolic acid levels are associated with donor-specific antibody formation","volume":"20","author":"Filler","year":"2016","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0012","doi-asserted-by":"crossref","first-page":"e14456","DOI":"10.1111\/ctr.14456","article-title":"Progressive decline of function in renal allografts with normal 1-year biopsies: gene expression studies fail to identify a classifier","volume":"35","author":"Park","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0013","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1600-6143.2006.01693.x","article-title":"Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients","volume":"7","author":"Budde","year":"2007","journal-title":"Am J Transplantat"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0014","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0015","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0016","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007890-199701150-00008","article-title":"Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups","volume":"63","author":"Halloran","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0017","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1432-2277.2006.00421.x","article-title":"Discontinuation of mycophenolate mofetil from a tacrolimus-based triple regimen 2 months after renal transplantation: a comparative randomized, multicentre study","volume":"20","author":"Su\u0142owicz","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0018","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-6143.2004.00638.x","article-title":"Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial","volume":"5","author":"Vanrenterghem","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.tp.0000225806.80890.5e","article-title":"Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant","volume":"82","author":"Pascual","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0020","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/jgs.13130","article-title":"Trends in kidney transplant outcomes in older adults","volume":"62","author":"McAdams-DeMarco","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 5","key":"10.1016\/j.transproceed.2024.10.034_bib0021","article-title":"Aging of the Immune System. Mechanisms and Therapeutic Targets","volume":"13","author":"Weyand","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0022","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.ki.5002247","article-title":"Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender","volume":"71","author":"Khamash","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0023","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1600-6143.2005.01050.x","article-title":"Predicting subsequent decline in kidney allograft function from early surveillance biopsies","volume":"5","author":"Cosio","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0024","doi-asserted-by":"crossref","first-page":"19379","DOI":"10.1038\/s41598-020-76379-6","article-title":"Initial mycophenolate dose in tacrolimus treated renal transplant recipients, a cohort study comparing leukopaenia, rejection and long-term graft function","volume":"10","author":"Dave","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/j.ajkd.2021.12.011","article-title":"Principles of immunosuppression in the management of kidney disease: Core Curriculum 2022","volume":"80","author":"Kant","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0026","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2215\/CJN.07111009","article-title":"Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation","volume":"5","author":"Kuypers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2024.10.034_bib0027","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the Banff classification of renal allograft pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524005748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524005748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T15:11:58Z","timestamp":1734102718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524005748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0041134524005748"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.10.034","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physician-Directed Mycophenolate Mofetil Dose Reduction After Kidney Transplantation: A Multicenter Real Word Experience","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}